Implantable cardioverter-defibrillators: Clinical aspects

Cardiac Electrophysiology: From Cell to Bedside

Volumn , Issue , 2004, Pages 980-994

  Swerdlow, Charles D ^a   Shivkumar, Kalyanam ^b  

^a UNIVERSITY OF CALIFORNIA   (United States)

^b UNIVERSITY OF CALIFORNIA   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

EID: 85076647339     PISSN: None     EISSN: None     Source Type: Book    
DOI: 10.1016/B0-7216-0323-8/50110-X     Document Type: Chapter

References (55)

1. SJ Connolly., AP Hallstrom., R Cappato., et al. Meta-analysis of the implantable cardioverter defibrillator secondary prevention trials. AVID, CASH and CIDS studies. Antiarrhythmics vs Implantable Defibrillator study. Cardiac Arrest Study Hamburg. Canadian Implantable Defibrillator Study Eur Heart J 21 2000 2071-2078.
2. AJ Moss., W Zareba., WJ Hall., et al. Prophylactic implantation of a defibrillator in patients with myocardial infarction and reduced ejection fraction N Engl J Med 346 2002 877-883.
3. JN Ruskin., AJ Camm., DP Zipes., et al. Implantable cardioverter defibrillator utilization based on discharge diagnoses from Medicare and managed care patients J Cardiovasc Electrophysiol 13 2002 38-43.
4. Gregoratos G, Abrams J, Epstein A, et al. ACC/AHA/NASPE 2002 guideline update for implantation of cardiac pacemakers and antiarrhythmia devices: A report of the American College of Cardiology/American Heart Association Task Force on Practice Guidelines (ACC/AHA/NASPE Committee on Pacemaker Implantation), 2002: Available at www.acc.org/clinical/guidelines/pacemaker/pacemaker.pdf.
5. A comparison of antiarrhythmic-drug therapy with implantable defibrillators in patients resuscitated from near-fatal ventricular arrhythmias: The Antiarrhythmics versus Implantable Defibrillators (AVID) Investigators N Engl J Med 337 1997 1576-1583 p993.
6. W Schoels., CD Swerdlow., W Jung., et al. Worldwide clinical experience with a new dual-chamber implantable cardioverter defibrillator system J Cardiovasc Electrophysiol 12 2001 521-528.
7. CD Swerdlow Implantation of cardioverter defibrillators without induction of ventricular fibrillation Circulation 103 2001 2159-2164.
8. A Natale., J Sra., K Axtell., et al. Undetected ventricular fibrillation in transvenous implantable cardioverter-defibrillators: Prospective comparison of different lead system-device combinations Circulation 93 1996 91-98.
9. M Glikson., JM Trusty., SK Grice., et al. A stepwise testing protocol for modern implantable cardioverter-defibrillator systems to prevent pacemaker-implantable cardioverter-defibrillator interactions Am J Cardiol 83 1999 360-366.
10. K Shivkumar., Z Feliciano., NG Boyle., I Wiener Intradevice interaction in a dual chamber implantable cardioverter defibrillator preventing ventricular tachyarrhythmia detection J Cardiovasc Electrophysiol 11 2000 1285-1288.
11. PJ DeGroot., TR Church., R Mehra., et al. Derivation of a defibrillator implant criterion based on probability of successful defibrillation Pacing Clin Electrophysiol 20 1997 1924-1935.
12. H Li., RA Malkin An approximate bayesian up-down method for estimating a percentage point on a dose-response curve J Appl Stat 27 2000 579-587.
13. MR Gold., S Higgins., R Klein., et al. Efficacy and temporal stability of reduced safety margins for ventricular defibrillation: Primary results from the Low Energy Safety Study (LESS) Circulation 105 2002 2043-2048.
14. C Swerdlow., D Martin., R Kass., et al. The zone of vulnerability to T-wave shocks in humans J Cardiovasc Electrophysiol 8 1997 145-154.
15. C Swerdlow., C Peter., C Hwang., et al. Programming of implantable defibrillators based on the upper limit of vulnerability rather than the defibrillation threshold Circulation 95 1997 1497-1504.
16. C Swerdlow., T Ahern., R Kass., et al. Upper limit of vulnerability is a good estimator of shock strength associated with 90% probability of successful defibrillation in humans with transvenous implantable cardioverter defibrillators J Am Coll Cardiol 27 1996 1112-1117.
17. C Swerdlow., S Davie., T Ahern., PS Chen Comparative reproducibility of defibrillation threshold and upper limit of vulnerability Pacing Clin Electrophysiol 19 1996 2103-2111.
18. FE Marchlinski., B Flores., JM Miller., et al. Relation of the intraoperative defibrillation threshold to successful postoperative defibrillation with an automatic implantable cardioverter defibrillator Am J Cardiol 62 1988 393-398.
19. SA Strickberger., KC Man., J Souza., et al. A prospective evaluation of two defibrillation safety margin techniques in patients with low defibrillation energy requirements J Cardiovasc Electrophysiol 9 1998 41-46.
20. RA Malkin., JM Herre., L McGowen., et al. A four-shock Bayesian up-down estimator of the 80% effective defibrillation dose J Cardiovasc Electrophysiol 10 1999 973-980.
21. T Tokano., F Pelosi., M Flemming., et al. Long-term evaluation of the ventricular defibrillation energy requirement J Cardiovasc Electrophysiol 9 1998 916-920.
22. Pelosi F Jr., H Oral., MH Kim., et al. Effect of chronic amiodarone therapy on defibrillation energy requirements in humans J Cardiovasc Electrophysiol 11 2000 736-740.
23. DM Hodgson., MR Olsovsky., SR Shorofsky., et al. Clinical predictors of defibrillation thresholds with an active pectoral pulse generator lead system Pacing Clin Electrophysiol 25 2002 408-413.
24. B Merkely., A Lubinski., O Kiss., et al. Shortening the second phase duration of biphasic shocks: Effects of class III antiarrhythmic drugs on defibrillation efficacy in humans J Cardiovasc Electrophysiol 12 2001 824-827.
25. P Dorian Amiodarone and defibrillation thresholds: A clinical conundrum J Cardiovasc Electrophysiol 11 2000 741-743.
26. MR Gold., MR Olsovsky., PJ DeGroot., et al. Optimization of transvenous coil position for active can defibrillation thresholds J Cardiovasc Electrophysiol 11 2000 25-29.
27. R Gradaus., M Block., K Seidl., et al. Defibrillation efficacy comparing a subcutaneous array electrode versus an “active can” implantable cardioverter defibrillator and a subcutaneous array electrode in addition to an “active can” implantable cardioverter defibrillator: Results from active can versus array trials I and II J Cardiovasc Electrophysiol 12 2001 921-927.
28. G Mouchawar., M Kroll., JE Val-Mejias., et al. ICD waveform optimization: A randomized, prospective, pair-sampled multicenter study Pacing Clin Electrophysiol 23 2000 1992-1995.
29. SR Shorofsky., MR Gold Effects of waveform and polarity on defibrillation thresholds in humans using a transvenous lead system Am J Cardiol 78 1996 313-316.
30. A Schaumann., F von zur Muhlen., B Herse., et al. Empirical versus tested antitachycardia pacing in implantable cardioverter defibrillators: A prospective study including 200 patients Circulation 97 1998 66-74.
31. MS Wathen., MO Sweeney., PJ DeGroot., et al. Shock reduction using antitachycardia pacing for spontaneous rapid ventricular tachycardia in patients with coronary artery disease Circulation 104 2001 796-801.
32. D Bansch., M Castrucci., D Bocker., et al. Ventricular tachycardias above the initially programmed tachycardia detection interval in patients with implantable cardioverter-defibrillators: Incidence, prediction and significance J Am Coll Cardiol 36 2000 557-565.
33. CD Swerdlow Supraventricular tachycardia-ventricular tachycardia discrimination algorithms in implantable cardioverter defibrillators: State-of-the-art review J Cardiovasc Electrophysiol 12 2001 606-612.
34. SL Pinski., GJ Fahy The proarrhythmic potential of implantable cardioverter-defibrillators Circulation 92 1995 1651-1664.
35. P Dorian., D Newman., B Thibault., et al. A randomized clinical trial of a standardized protocol for the prevention of inappropriate therapy using a dual chamber implantable cardioverter defibrillator [abstract] Circulation 1 1999 I-786.
36. BL Wilkoff., V Kuhlkamp., K Volosin., et al. Critical analysis of dual-chamber implantable cardioverter-defibrillator arrhythmia detection: Results and technical considerations Circulation 103 2001 381-386.
37. M Lloyd., D Hayes., P Friedman Troubleshooting D Hayes., M Lloyd. P Friedman Cardiac Pacing and Defibrillation: A Clinical Approach 2000 Futura Armonk, NY 347-452.
38. B Gunderson., A Patel., C Bounds Automatic identification of implantable cardioverter-defibrillator lead problems using intracardiac electrograms Comput Cardiol 29 2002 121-124.
39. J Schreieck., B Zrenner., C Kolb., et al. Inappropriate shock delivery due to ventricular double detection with a biventricular pacing implantable cardioverter defibrillator Pacing Clin Electrophysiol 24 2001 1154-1157.
40. MO Sweeney., KE Ellison., JB Shea., JB Newell Provoked and spontaneous high-frequency, low-amplitude, respirophasic noise transients in patients with implantable cardioverter defibrillators J Cardiovasc Electrophysiol 12 2001 402-410.
41. A Pacifico., SH Hohnloser., JH Williams., et al. Prevention of implantable-defibrillator shocks by treatment with sotalol. d,l-Sotalol Implantable Cardioverter-Defibrillator Study Group N Engl J Med 340 1999 1855-1862.
42. N Goldschlager., A Epstein., P Friedman., et al. Environmental and drug effects on patients with pacemakers and implantable cardioverter/defibrillators: A practical guide to patient treatment Arch Intern Med 161 2001 649-655.
43. EB Schron., DV Exner., Q Yao., et al. Quality of life in the antiarrhythmics versus implantable defibrillators trial: Impact of therapy and influence of adverse symptoms and defibrillator shocks Circulation 105 2002 589-594.
44. AE Epstein., WM Miles., DG Benditt., et al. Personal and public safety issues related to arrhythmias that may affect consciousness: Implications for regulation and physician recommendations-A medical/scientific statement from the American Heart Association and the North American Society of Pacing and Electrophysiology Circulation 94 1996 1147-1166.
45. T Akiyama., JL Powell., LB Mitchell., et al. Resumption of driving after life-threatening ventricular tachyarrhythmia N Engl J Med 345 2001 391-397.
46. SL Pinski., RG Trohman Interference in implanted cardiac devices, part II Pacing Clin Electrophysiol 25 2002 1496-1509.
47. SL Pinski., RG Trohman Interference in implanted cardiac devices, Part I Pacing Clin Electrophysiol 25 2002 1367-1381.
48. PJ Best., DL Hayes., MS Stanton The potential usage of dual chamber pacing in patients with implantable cardioverter defibrillators Pacing Clin Electrophysiol 22 1999 79-85.
49. BL Wilkoff., JR Cook., AE Epstein., et al. Dual Chamber and VVI Implantable Defibrillator Trial Investigators Dual-chamber pacing or ventricular backup pacing in patients with an implantable defibrillator: The Dual Chamber and VVI Implantable Defibrillator (DAVID) Trial JAMA 288 2002 3115-3123 p994.
50. B Hügl., K Ziegenbalg., A Grosse., et al. Are enhanced dual chamber detection algorithm superior to single chamber algorithm? Long term results of the multicenter ICD-Trial DETECT Circulation 106 2002 II-321.
51. The Companion Trial Investigators To be presented at ACC Meeting 2003 J Am Coll Cardiol 2003.
52. V Kuhlkamp Initial experience with an implantable cardioverter-defibrillator incorporating cardiac resynchronization therapy J Am Coll Cardiol 39 2002 790-797.
53. C Butter., E Meisel., J Tebbenjohanns., et al. Transvenous biventricular defibrillation halves energy requirements in patients Circulation 104 2001 2533-2538.
54. DP Zipes Implantable cardioverter-defibrillator: A Volkswagen or a Rolls Royce-how much will we pay to save a life? Circulation 103 2001 1372-1374.
55. WH Olson Tachyarrhythmia Sensing and Detection I Singer. Implantable Cardioverter Defibrillator 1994 Futura Armonk, NY 71-107.